Skip to main content

Fifth Third Bancorp

SEC CIK
0000035527
Latest filing
Aug 5, 2026

CRVS holding history

Corvus Pharmaceuticals, Inc. in every 13F filed by Fifth Third Bancorp, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

CRVS overviewAll 13F holders of CRVSFull Q2 2026 holdings

Shares (Q2 2026)
271
Value
$4.05K
% of portfolio
<0.1%
Quarters held
2
Since Q1 2026
Holdings of CRVS by Fifth Third Bancorp, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026271$4.05K<0.1%+250+1,190.5%AddedHolders
Q1 202621$307<0.1%+21NewHolders